Brief: S2Medical Granted Patent Protection For IvaQ In South Africa
31/03/2025 15:41
March 31 (Reuters) - S2Medical AB (publ) S2ME.ST: GRANTED PATENT PROTECTION FOR IVAQ IN SOUTH AFRICA PATENT VALID FOR 20 YEARS FROM APPLICATION DATE Source text: ID:nWkr84pxLd Further company coverage: S2ME.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on S2Medical AB (publ)
See all newsBrief: Eyracure Company Part-owned By S2Medical Files For Bankruptcy
Brief: S2Medical Plans Rights Issue To Raise SEK 2.9 Mln
Brief: S2medical H2 Net Sales At SEK 7.5 Mln
Brief: S2medical Signs Exclusive Distribution Agreement In UAE
Brief: S2Medical Validates European Patent For AMP Technology In 18 Countries